trending Market Intelligence /marketintelligence/en/news-insights/trending/I8Ly167YoZWKu3Xg-PDPcQ2 content esgSubNav
In This List

CVS begins selling cannabis-based products in 8 states


Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Bed, Bath, and Bankruptcy: Using Quantitative Credit Models to Predict Corporate Defaults


Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback


Infographic: The Big Picture 2023 Sustainability Outlook

CVS begins selling cannabis-based products in 8 states

CVS Health Corp. has started selling products that contain cannabidiol, or CBD, in eight states, CNBC reported March 20, citing a company statement.

CBD is a nonintoxicating cannabis compound.

The pharmacy chain started selling CBD products in Alabama, California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee in the week of March 11, the report added. CVS said the products include creams, sprays, roll-ons, lotions and salves.

The retail and health care company added that it has partnered with CBD product manufacturers that "are complying with applicable laws and that meet CVS' high standards for quality."

In a separate report, CVS CEO Larry Merlo told CNBC that the chain is not selling any CBD-containing supplements or food additives.

Merlo reportedly said the company is going to "walk slowly" in the CBD space, but the executive added that "this is something that customers are going to be looking for as part of the health offering."